Sterling Pharma Solutions
Sterling Pharma Solutions, a leading contract development and manufacturing organisation (CDMO), is headquartered in Great Britain and operates across key regions including Europe and North America. Founded in 2015, the company has rapidly established itself in the pharmaceutical industry, specialising in the development and production of active pharmaceutical ingredients (APIs) and complex formulations. Sterling Pharma Solutions is renowned for its commitment to quality and innovation, offering bespoke services that cater to the unique needs of its clients. With a focus on regulatory compliance and sustainability, the company has achieved significant milestones, including successful partnerships with major pharmaceutical firms. Sterling's market position is bolstered by its state-of-the-art facilities and a dedicated team of experts, making it a trusted partner in the global pharmaceutical landscape.
DitchCarbon Score
How does Sterling Pharma Solutions's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sterling Pharma Solutions's score of 3 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sterling Pharma Solutions's reported carbon emissions
Sterling Pharma Solutions, headquartered in the United Kingdom, has not publicly disclosed specific carbon emissions data for the most recent year. However, the company is committed to reducing its carbon footprint and has established near-term reduction targets. As of April 2023, Sterling Pharma Solutions is actively engaged in initiatives aimed at minimising its environmental impact, although it has not set a net-zero target. The company operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector, which is increasingly focused on sustainability and climate action. Sterling Pharma Solutions' commitment to reducing emissions aligns with industry standards and reflects a growing trend among pharmaceutical companies to address climate change proactively. While specific emissions figures are not available, Sterling Pharma Solutions' commitment to reduction targets indicates a strategic approach to managing its carbon emissions, contributing to broader efforts within the industry to enhance sustainability and reduce environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sterling Pharma Solutions is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
